The acceleration is striking. GenAI patent families roughly doubled between 2024 and 2025. China alone published over 43,000 patent families in that two-year span—exceeding its entire output from the prior decade. Within the technology mix, large language models have overtaken GANs as the dominant GenAI patent category. The precise breakdown of which Chinese companies are filing in 2024-2025 remains unclear.
Patent volume serves as a proxy for R&D spending, commercial intent, and technological positioning in foundational AI systems. For in-house counsel and policy practitioners, the WIPO data crystallizes what has been a diffuse competitive concern into measurable terms. The caveat: patent filings do not directly correlate with deployed product quality or market success. Still, the velocity and concentration of Chinese GenAI patenting warrant close monitoring by firms developing AI strategy or advising on technology policy.